Sinovac Biotech ( Sinovac Biotech )

Sinovac Biotech

Sinovac Biotech's picture

inovac Biotech Ltd. is a biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases. The company is based in Beijing, China.
inovac's commercialized vaccines include Healive (hepatitis A), Bilive (combined hepatitis A and B), Anflu (influenza), Panflu (H5N1) and PANFLU.1 (H1N1). Sinovac is currently developing Universal Pandemic Influenza vaccine and Japanese encephalitis vaccine.[1]

Sinovac is developing vaccines for enterovirus 71, universal pandemic influenza, Japanese encephalitis, and human rabies. Its wholly owned subsidiary, Tangshan Yian, is conducting field trials for independently developed inactivated animal rabies vaccines.

Sinovac Biotech press release, blog etc

12/29/2017 - 02:34 Sinovac Schedules 2017 Annual Meeting of Shareholders
12/22/2017 - 09:20 Sinovac Biotech Receives Positive Decision on its Hepatitis A Vaccine from World Health Organization
11/08/2017 - 19:24 Sinovac Biotech Announces Request Hearing before Nasdaq Hearings Panel
11/03/2017 - 16:37 Sinovac Biotech Announces Receipt of DelistingDetermination Letter fromNasdaq
09/25/2017 - 04:37 Sinovac Reports Preliminary Top-Line Results from Phase III Clinical Trial for Varicella Vaccine Candidate Against Chickenpox
08/14/2017 - 04:01 Sinovac Biotech Announces Certain Updates Relating to Delayed Filing of Annual Report on Form 20-F
06/26/2017 - 10:37 Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction
05/16/2017 - 11:47 Sinovac Biotech Announces Receipt of NASDAQ Letter
12/23/2016 - 06:52 Sinovac Responds to Recent Report
11/07/2016 - 06:36 Sinovac Announces Results of 2016 Annual General Meeting of Shareholders
09/30/2016 - 04:32 Sinovac Schedules 2016 Annual Meeting of Shareholders
04/14/2016 - 05:37 Sinovac Special Committee Engages Financial and Legal Advisors
03/28/2016 - 19:19 Sinovac Adopts Shareholder Rights Plan and Declares Dividend Distribution of Preferred Share Purchase Rights
02/04/2016 - 08:00 Sinovac Announces Receipt of Competing Non-Binding Going Private Proposal
02/01/2016 - 05:23 Sinovac Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Independent Special Committee
01/04/2016 - 04:23 Sinovac Obtains New Drug Certificate and Production License for EV71 Vaccine
12/10/2015 - 09:06 Sinovac Obtains Clinical Trial Approval for Sabin-IPV Candidate
10/26/2015 - 04:45 Sinovac Receives Clinical Trial Approval for Varicella Vaccine Candidate